Latest The Texas Heart Institute Stories
HOUSTON, June 29, 2011 /PRNewswire/ -- Texas Children's Hospital in Houston announced today that it is the first pediatric hospital in the United States to implant an artificial heart into the chest of a 17-year-old patient as the only option to save his life.
Pluromed, Inc. announced today the addition of Dr. William E. Cohn to its board of directors. On March 10, 2011, Dr. Cohn and Dr.
New device is designed to improve survival rates from heart attack in high-risk heart patients. NEPTUNE, N.J., March 24, 2011 /PRNewswire-USNewswire/ -- Today at Jersey Shore University Medical Center, 66-year-old heart attack survivor Charles Theodora from Ocean Township became the first NY/NJ Metropolitan resident to be implanted with the experimental AngelMed Guardian cardiac monitor and alert system device that could alert him if a heart attack is imminent.
Two Turkish Hospitals and Two U.S. Centers to Complete Phase I in January Tucson, Ariz. (Vocus/PRWEB) January 20, 2011 On Jan. 20, SynCardia Systems, Inc.
ALLENDALE, N.J., Dec. 21, 2010 /PRNewswire/ -- The American Heart Journal today reported results of a clinical trial evaluating Amorcyte, Inc.'s lead product candidate, AMR-001 for the treatment of damaged heart muscle following acute myocardial infarction (AMI).
Texans For Stem Cell Research Event Brings International Biomedical Science Leaders to Austin October 27th - Free and Open to Public.
Texans For Stem Cell Research Event Brings International Biomedical Science Leaders to Austin October 27th - Free and Open to Public Texans for Stem Cell Research (TCSR), a non-profit grassroots organization, announces an educational event about stem cell research and advances in their first Annual Learn and Live Educational Series, at the University of Texas Joe C.
SAN DIEGO, Sept. 14 /PRNewswire/ -- The 14th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a discussion titled "Latest Developments in Stem Cell and Gene Therapy in Heart Failure" which includes a presentation by Dr.
A state-of-the-art heart pump recently approved for use in end-stage cardiac patients has a significantly lower risk for infection than an earlier model of the device.
University of Utah heart surgeon implants VAD in Idaho man as part of national clinical trial.